ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy
Event:
ESC CONGRESS 2020 - The Digital Experience
Topic:
Hypertrophic Cardiomyopathy
Session type:
Best ePosters
Date:
30 August 2020
Time:
08:30 - 08:30
Session
0
4
presentations
in this session
Lifetime mortality associated with hypertrophic cardiomyopathy: 28-year outcome of an historical cohort
Speaker:
Mr N. Maurizi (Florence, IT)
Access
Abstract
Slides
0
What happens >10 years after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy? Ultra long-term follow-up of 120 patients.
Speaker:
Professor L. Faber (Bad Oeynhausen, DE)
Access
Abstract
Slides
0
Is alcohol septal ablation in women performed too late?
Speaker:
Doctor A. Batzner (Wurzburg, DE)
Access
Abstract
Slides
0
High sensitivity troponin I in hypertrophic cardiomyopathy
Speaker:
Doctor J. Osmanska (Glasgow, GB)
Access
Abstract
Slides
0
4
speakers
from this session
Mr Niccolo' Maurizi
University of Florence, Florence (Italy)
0
follower
Professor Lothar Faber
Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen (Germany)
0
follower
Doctor Angelika Batzner
University Hospital of Wurzburg, Wurzburg (Germany)
0
follower
Doctor Joanna Osmanska
Golden Jubilee National Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)
1
presentation
0
follower
This platform is supported by